DOD P&T Committee: 2024 Meetings

Nov. 6-7, 2024

Uniform Formulary Request for Quote Information opens to Uniform Formulary Request for Quote Information

Uniform Formulary Request for Quote Information opens to Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: July 18, 2024
  • Pre-Proposal Teleconference: July 24, 2024 at 1 p.m. CT
  • UF BPA & UF ADP Class Quotes Due: Sept. 19, 2024 at 12 p.m. CT

*Please note that all agents in the class, including brands and all generics, may be considered for formulary management actions. Additionally, if a drug is approved prior to Aug. 27, 2015, but not currently available the committee may still make a formulary recommendation.

Class Review Designated Newly Approved Drugs Utilization Management
  • MIGRAINE AGENTS - ORAL CGRP:

    • Nurtec ODT

    • Qulipta

    • Ubrelvy

  • TARGETED IMMUNOMODULATORY BIOLOGICS - INTERLEUKIN 17 (IL-17):

    • Bimzelx

    • Cosentyx

    • Siliq

    • Taltz

  • TARGETED IMMUNOMODULATORY BIOLOGICS - INTERLEUKIN 23 (IL-23):

    • Ilumya

    • Omvoh

    • Skyrizi

    • Stelara

    • Tremfya

  • Aqneursa

  • Clobetasol propionate ophthalmic suspension

  • Cobenfy

  • Crexont

  • Ebglyss

  • Femlyv

  • Lazcluze

  • Livdelzi

  • Neffy

  • Nemluvio

  • Ohtuvayre

  • Onyda XR

  • Sofdra

  • Tryvio

  • Vafseo

  • Vigafyde

  • Voranigo

  • Yorvipath

  • Zepbound

 

 

 

Aug. 7-8, 2024

Uniform Formulary Request for Quote Informationopens to Uniform Formulary Request for Quote Information

Uniform Formulary Request for Quote Information opens Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: April 22, 2024
  • Pre-Proposal Teleconference: April 24, 2024 at 1 p.m. CT
  • UF BPA & UF ADP Class Quotes Due: June 13, 2024 at 12 p.m. CT

*Please note that all agents in the class, including brands and all generics, may be considered for formulary management actions. Additionally, if a drug is approved prior to Aug. 27, 2015, but not currently available the committee may still make a formulary recommendation.

Class Review Designated Newly Approved Drugs Utilization Management
  • ANTILIPIDEMICS-1 AGENTS - NON-STATIN and COMBOS:

    • Nexletol

    • Nexlizet

  • ANTILIPIDEMICS-1 AGENTS - STATINS:

    • Altoprev

    • Atorvaliq

    • Ezallor Sprinkle

    • Flolipid

    • Zypitamag

  • LEUKEMIA and LYMPHOMA AGENTS - BRUTON TYROSINE KINASE INHIBITORS:

    • Brukinsa

    • Calquence

    • Imbruvica

    • Jaypirca

  • Duvyzat

  • Humira (Cordavis)

  • Iqirvo

  • Libervant TM

  • Myhibbin

  • Ojemda

  • Opsynvi

  • Rextovy

  • Rezdiffra

  • Simlandi

  • Sitagliptin/metformin

  • Spevigo

  • Tyenne

  • Voydeya

  • Winrevair

  • Xolremdi

 

 

 

May 1-2, 2024

Uniform Formulary Request for Quote Informationopens to Uniform Formulary Request for Quote Information

Uniform Formulary Request for Quote InformationUniform Formulary Request for Quote Information (New Drug Class) (New Drug Class)opens to Uniform Formulary Request for Quote Information (New Drug Class)

  • UF BPA & UF ADP RFQ Documents Posted: Jan. 31, 2024
  • Pre-Proposal Teleconference: Jan. 31, 2024 at 1 p.m. CT
  • UF BPA & UF ADP Class Quotes Due: Mar. 21, 2024 at 12 p.m. CT

*Please note that all agents in the class, including brands and all generics, may be considered for formulary management actions. Additionally, if a drug is approved prior to Aug. 27, 2015, but not currently available the committee may still make a formulary recommendation.

Class Review Designated Newly Approved Drugs Utilization Management
  • INSULINS - BASAL:

    • Basaglar Kwikpen U-100

    • Basaglar Tempo Pen U-100

    • Insulin Degludec

    • Insulin Degludec Pen U-100

    • Insulin Degludec Pen U-200

    • Insulin Glargine

    • Insulin Glargine Solostar

    • Insulin Glargine-YFGN

    • Lantus

    • Lantus Solostar

    • Levemir

    • Levemir Flexpen

    • Levemir Flextouch

    • Rezvoglar Kwikpen

    • Semglee

    • Semglee-YFGN

    • Semglee-YFGN Pen

    • Semglee Pen

    • Toujeo Max Solostar

    • Toujeo Solostar

    • Tresiba

    • Tresiba Flextouch U-100

    • Tresiba Flextouch U-200

  • WEIGHT LOSS AGENTS - NA:

    • Apidex-P

    • Contrave

    • Lomaira

    • Orlistat

    • Qsymia

    • Saxenda

    • Wegovy

    • Xenical

    • Zepbound

  • PULMONARY II AGENTS - INHALED CORTICOSTERIODS:

    • Alvesco

    • Armonair Digihaler

    • Arnuity Ellipta

    • Asmanex

    • Asmanex HFA

    • Flovent Diskus

    • Flovent HFA

    • FluticasonePropionate HFA

    • Pulmicort Flexhaler

    • Qvar Redihaler

  • Agamree

  • Alvaiz

  • Bosulif

  • Eohilia

  • Fabhalta

  • Filsuvez

  • Iwilfin

  • Rivfloza

  • Vevye

  • Wainua

  • Xolair Auto-injector

  • Zilbrysq

  • Zituvio

  • Zoryve

  • Zymfentra

 

 

 

Feb. 7-8, 2024

Uniform Formulary Request for Quote Information opens to Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: Oct. 26, 2023
  • Pre-Proposal Teleconference: Nov. 8, 2023 at 1 p.m. CT
  • UF BPA & UF ADP Class Quotes Due: Dec. 21, 2023 at 12 p.m. CT

*Please note that all agents in the class, including brands and all generics, may be considered for formulary management actions. Additionally, if a drug is approved prior to Aug. 27, 2015, but not currently available the committee may still make a formulary recommendation.

Class Review Designated Newly Approved Drugs Utilization Management
  • GROWTH STIMULATING AGENTS - NA:

    • Genotropin

    • Humatrope

    • Ngenla

    • Norditropin Flexpro

    • Nutropin AQ Nuspin

    • Omnitrope

    • Saizen

    • Saizen-Saizenprep

    • Serostim

    • Skytrofa

    • Sogroya

    • Zomacton

  • Abrilada

  • Augtyro

  • Bimzelx

  • Cabtreo

  • Coxanto

  • Entyvio

  • Fruzaqla

  • Jesduvroq

  • Jylamvo

  • Likmez

  • Motpoly XR

  • Ogsiveo

  • Ojjaara

  • Omvoh

  • Truqap

  • Velsipity

  • Voquezna

  • Xalkori

  • Xphozah

  • Zepbound

  • Zurzuvae
  • PRIOR AUTHORIZATION UPDATES:

    • Adbry

    • Besremi

    • Cosentyx

    • Enbrel

    • Forteo

    • Jaypirca

    • Lidocan

    • Lynparza

    • Mektovi

    • Nubeqa

    • Orencia

    • Pokonza

    • Rozlytrek

    • Tibsovo

    • Venclexta

    • Voxzogo

    • Welireg

    • Xtandi

    • Yonsa

    • Zoryve

    • Zytiga